AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT01404143 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: subscapularis peel
Description: The subscapularis will be elevated from the lesser tuberosity. The tendon will be tagged with stay sutures for later reattachment (3 sutures in mattress configuration). Reapproximation will take place with three non-absorbable mattress sutures placed in a trans-osseous fashion through the bicipital groove, exiting the greater tuberosity and tied over a 4-hole mini-fragment plate.
Study NCT02453152 — intervention group
Intervention type: OTHER
Intervention: History and physical
Description: Subjects will undergo a physical exam and medical history review, including review of genetic test results.
Study NCT02453152 — intervention group
Intervention type: OTHER
Intervention: Tidal breathing
Description: Subjects' breathing patterns will be evaluated at rest and at reduced/eliminated ventilator support.
Study NCT02453152 — intervention group
Intervention type: OTHER
Intervention: Maximal respiratory pressures
Description: Subjects' strongest inspiratory and expiratory pressures will be measured.
Study NCT03781596 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Fluticasone
Description: Participants in the experimental and placebo arms will be given swallowed fluticasone for an 8 week course. Doses determined by age and weight.
Study NCT03781596 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Omeprazole
Description: The participants in the experimental arm will be given oral omprazole capsules for an 8 week period (along with the swallowed fluticasone). Doses determined by age and weight.
Study NCT03781596 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo oral capsule
Description: The participants in the placebo arm will be given placebo capsules for an 8 week period (along with the swallowed fluticasone). Number of pills determined by age and weight (to match omeprazole dosing).
Study NCT03882450 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Flexible fiberoptic laryngoscopy
Description: Flexible fiberoptic laryngoscopy with examination and video documentation of laryngeal function preoperatively (if the participant is not intubated and is stable enough to do so) and postoperatively with a 2.4mm flexible laryngoscope will be performed.
Study NCT03882450 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Laryngeal ultrasonography
Description: Laryngeal ultrasonography will be performed using a portable ultrasound system while the participants are awake.
Study NCT03185052 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Manual puncture point compression
Description: Manual puncture point compression following a diagnostic or therapeutic procedure by endovascular technique involving retrograde femoral puncture point with 5F guide catheter
Study NCT02019459 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Very low nicotine content cigarettes
Study NCT02019459 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: standard nicotine content cigarettes
Study NCT02757469 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Drospirenone and ethinyl estradiol combination (Yasmin)
Description: Female oral combined contraceptive containing 30 mcg (0.030 mg) Ethinyl Estradiol and 3 mg drospirenone (Androstenes)
Study NCT03449771 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: self-administered questionnaire
Description: The newsletter and a self-questionnaire will be systematically given in the waiting room to any PrEP consultant to evaluate the consumption of psychoactive substances (ASSIST questionnaire) and to identify anxio-depressive disorders (HAD questionnaire - Hospital Anxiety and Depression). scale).
Study NCT01333605 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: IGEV
Description: Ifosfamide 1200 mg/m2 at days 1-4, Mesna 400 mg 0,4,8h at days 1-4, Gemcitabine 800 mg/m2 at day 1 and day 4, Vinorelbine 20 mg/m2 at day 1, Prednisone 100 mg at days 1-4. Frequency of cycles: every 3 weeks. Numbers of cycles: 4 cycles.
Study NCT00679770 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AN2690, 2.5%
Description: Once daily application for 90 days and 3 x weekly for 90 days
Study NCT00679770 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AN2690, 5%
Description: Once daily application for 90 days and 3 x weekly for 90 days
Study NCT00679770 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AN2690, 7.5%
Description: Once daily application for 90 days and 3 x weekly for 90 days
Study NCT00679770 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Vehicle
Description: Once daily application for 90 days and 3x weekly for 90 days
Study NCT02681900 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Self-affirmation manipulation task
Description: Participants in the self-affirmation condition indicate their most important value, give three examples of why this value is important to them and one example of something they had done to demonstrate its importance.
Study NCT02681900 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Control task
Description: People in the control condition indicate their least important value, three examples of why that value could be important to someone else, and describe something that person could do to show its importance.
Study NCT01715194 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Telemedicine intervention
Description: Patients undergoing telemedicine intervention
Study NCT02463994 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: MPDL3280A
Description: Patients will receive 1,200 mg I.V. Q 3 weeks of MPDL3280A until progression.
Study NCT02463994 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Hypofractionated Radiotherapy
Description: Hypofractionated Image-Guided Radiotherapy (HIGRT)
Study NCT01550029 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Counseling/Managing Mood
Description: A trained counselor will meet with subjects for approximately 60 minutes each week during the 12-week treatment period to provide support for quitting smoking and to help develop knowledge and skills for quitting. Also, subjects will receive the National Cancer Institute's Clearing the Air guide to smoking cessation. Some specific areas of focus for this intervention are managing negative moods without smoking and overcoming other obstacles to quitting.
Study NCT03888781 — intervention group
Intervention type: DEVICE
Intervention: Echocardiography
Description: An echocardiogram (also called an echo) is a type of ultrasound test that uses high-pitched sound waves that are sent through a device called a transducer. The device picks up echoes of the sound waves as they bounce off the different parts of your heart. These echoes are turned into moving pictures of your heart that can be seen on a video screen.
Study NCT00746876 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Unipolar hip hemiarthroplasty
Description: Unipolar hip hemiarthroplasty for the treatment of femoral neck fractures
Study NCT00746876 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Bipolar hip hemiarthroplasty
Description: Bipolar hip hemiarthroplasty for the treatment of femoral neck fractures
Study NCT02292173 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Trametinib
Description: Dose Escalation:~Level 1: 1 mg daily. Level 2: 1.5 mg daily. Level 3: 1.5 mg daily. Level 4: 2 mg daily.~Dose Expansion:~Maximum Tolerated Dose (MTD)
Study NCT02292173 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sorafenib
Description: Dose Escalation:~Level 1: 200 mg twice daily. Level 2: 200 mg twice daily. Level 3: 400 mg twice daily. Level 4: 400 mg twice daily.~Dose Expansion:~Maximum Tolerated Dose (MTD)
Study NCT04448652 — intervention group
Intervention type: DRUG
Intervention: NSAID
Description: no other intervention than described in the groups.
Study NCT03840369 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Repetitive Transcranial Magnetic Stimulation to Right Dorsolateral Prefrontal Cortex
Description: Transcranial magnetic stimulation (TMS) works by delivering a magnetic pulse to a focal brain region. TMS has a high degree of safety and has been studied as an intervention for many mental health and neurological conditions. Repetitive TMS (rTMS) delivers pulses at a set time interval in order to modulate neural activity in that region.
Study NCT01687751 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine
Description: Study drugs will be administered by continuous subcutaneous infusion using a weight based protocol at a rate between 1.0 to 5.5 mL/hr.~* The study drug will be started at a rate of 1.0 mL/hr.~* The infusion rate is incremented by 0.5 ml/hr every 30 minutes until acceptable symptom control, bradycardia (heart rate \< 40) or hypotension (systolic blood pressure \< 80) prevent further increase or maximum infusion rate of 5.5 ml/hr, whichever comes first. Achievement of acceptable symptom control will be defined, for purposes of this trial, as a consensus between reports from patient, family care giver and attending registered nurse
Study NCT03840369 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Sham Repetitive Transcranial Magnetic Stimulation
Description: The sham TMS coil will make a similar sound to the real rTMS coil, but will not deliver a magnetic pulse. This is a no-treatment device.
Study NCT03840369 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Repetitive Transcranial Magnetic Stimulation to Right Dorsomedial Prefrontal Cortex
Description: Transcranial magnetic stimulation (TMS) works by delivering a magnetic pulse to a focal brain region. TMS has a high degree of safety and has been studied as an intervention for many mental health and neurological conditions. Repetitive TMS (rTMS) delivers pulses at a set time interval in order to modulate neural activity in that region.
Study NCT03485365 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: GSK3858279 IV
Description: GSK3858279 will be available as solution for injection to be administered via IV route.
Study NCT02453152 — intervention group
Intervention type: OTHER
Intervention: Peak cough flow
Description: Subjects' strongest coughs will be measured.
Study NCT02453152 — intervention group
Intervention type: OTHER
Intervention: Pediatric Evaluation of Disability Inventory
Description: Assesses the functional capabilities of children with disabilities.
Study NCT02453152 — intervention group
Intervention type: OTHER
Intervention: PedsQL Multidimensional Fatigue Scale
Description: Assesses general fatigue, sleep/rest fatigue, and cognitive fatigue.
Study NCT02453152 — intervention group
Intervention type: OTHER
Intervention: Review of ventilation requirements
Description: Subjects's use of mechanical ventilation reviewed by the study team.
Study NCT00854724 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Puerarin, Placebo
Description: 400 mg, three times a day for 7 days
Study NCT00854724 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Puerarin, Placebo
Description: 400 mg, three times a day for 7 days
Study NCT04897230 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Hatha Yoga
Description: The yoga poses were chosen for providing a restorative session based on their purported relationship to restorative effects to best promote cardiac autonomic recovery from mental stress.
Study NCT04897230 — intervention group
Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: Video Watching
Description: The video was about the history of the Earth which encompasses the development of the planet Earth from its formation to the present day.
Study NCT04491682 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Megestrol Acetate
Description: At a dosage of 160 mg/day
Study NCT04491682 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Rosuvastatin
Description: At a dosage of 10 mg/day
Study NCT01882556 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: onabotulinumtoxinA
Study NCT01882556 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Study NCT03839849 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: : i-PRF
Description: The description of this intervention has been already given before
Study NCT03839849 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: saline
Description: The description of this intervention has been already given before
Study NCT02812264 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: API App
Description: Mobile application that uses API technology to deliver evidence-based weight loss intervention. Includes syncing with wearable fitness tracker and scale
Study NCT02812264 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Non-API App
Description: Mobile application that does not use API technology to deliver evidence-based weight loss intervention. Includes syncing with wearable fitness tracker and scale.
Study NCT02812264 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: fitness tracker
Description: fitness tracker to monitor physical activity and sleep patterns that is connected to transfer data to app
Study NCT02812264 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: fitness tracker
Description: fitness tracker to monitor physical activity and sleep patterns that is connected to transfer data to app
Study NCT02812264 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: scale
Description: Connected scale that will transfer weight information to app
Study NCT02812264 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: scale
Description: Connected scale that will transfer weight information to app
Study NCT03890926 — intervention group
Intervention type: RADIATION
Intervention: radioactive Iodine-125 seed implantation under the guidance of 3D template
Description: 3D-PNCT assisted with CT-guidance for radioactive Iodine-125 seed brachytherapy is a conventional treatment for patients with local recurrent rectal carcinoma. Retrospective data on the effectiveness and adverse effects of the past radioactive Iodine-125 seed implantation is collected.
Study NCT04106258 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Hemoporfin PDT
Description: Photodynamic therapy is performed using hemoporfin under general anesthesia. Hemoporfin（5mg/kg）is infused for 20 minutes, followed by light illumination at 10 minutes from the start of infusion. Different light dose of PDT is applied to the patients.
Study NCT01586598 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: sensory retraining protocol
Description: 1. within one month after the surgery: facial massage and physical stimulation over lower face and lip, four times (20 minutes each time) a day~2. one to three months after the surgery: brush and physical stimulation over lower face and lip, four times (20 minutes each time) a day~3. three to six months after the surgery: brush, pin and physical stimulation over lower face and lip, four times (20 minutes each time) a day
Study NCT01379248 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: manual thrombus aspiration (Export catheter, Medtronic Inc. Minneapolis, Minnesota, USA)
Description: manual thrombus aspiration catheter to be used during percutaneous coronary intervention
Study NCT04207411 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bupivacaine
Description: Injection of anesthetics blocks once a week during 4 weeks.
Study NCT04207411 — intervention group
Intervention type: DRUG
Group type: SHAM_COMPARATOR
Intervention: Bupivacaine
Description: Injection of anesthetics blocks once a week during 4 weeks.
Study NCT04207411 — intervention group
Intervention type: DRUG
Group type: SHAM_COMPARATOR
Intervention: Lidocaine
Description: Injection of anesthetics blocks once a week during 4 weeks.
Study NCT02706418 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: Clinical Massage Therapy
Study NCT02649959 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CM-AT
Description: Single unit does powder of active substance (CM-AT) administered 3 times per day
Study NCT04873141 — intervention group
Intervention type: DRUG
Intervention: Tocilizumab 200 Mg/10 mL (20 Mg/mL) INTRAVEN VIAL (ML)
Description: Tocilizumab was given according to weight in patients with cytokinme releasew syndrome (CRS).
Study NCT01807169 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Colonic polypectomy or endoscopic mucosal resection (EMR).
Description: Resection of colonic polyps using polypectomy tehnique (with electrocoagulation) or mucosal resection (EMR or mucosectomy) with injection of physiological serum thus resection with electrocoagulation
Study NCT00343395 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: AVANDAMET
Description: 2/500 mg
Study NCT02171806 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BI 1744 CL
Study NCT02171806 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Study NCT03485365 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: GSK3858279 SC
Description: GSK3858279 will be available as solution for injection to be administered via SC route.
Study NCT03485365 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo matching to GSK3858279 (SC or IV)
Description: Placebo will be available as sodium chloride solution to be administered via SC or IV route.
Study NCT02144402 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: infant formula with DHASCO
Study NCT03485365 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo matching to GSK3858279 (SC)
Description: Placebo will be available as sodium chloride solution to be administered via SC route.
Study NCT02837614 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: dexamethasone acetate
Description: 1 milliliter of dexamethasone (4milligram) administered in the deltoid muscle before commencement of surgical procedure
Study NCT02837614 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: submucosal dexamethasone injection
Description: Local anesthesia was achieved using 2% lignocaine hydrochloride and 1:100 000 adrenaline and a standard technique was followed to block Inferior alveolar, lingual and long buccal nerve in all patients. In Group B patients, 1 ml of dexamethasone was administered in submucosa. Investigators divided 1 ml Dexamethasone is into 0.4 milliliter, 0.3 milliliter and 0.3 milliliter parts. Following the local anesthesia, each part of dexamethasone was injected submucosally in the buccal, lingual and retromolar region around the tooth to be extracted. Bone removal done around the tooth using a round bur under copious 0.9% normal saline irrigation and tooth elevated. The flap was sutured using three simple interrupted 3-0 black braided silk suture. All patients were given amoxicillin 500 milligram every 8 hours orally for 5 days, and 500 milligram of paracetamol postoperatively.
Study NCT02837614 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Third molar surgery
Description: Surgical access was gained through standard Terrence Ward's incision to raise a full thickness mucoperiosteal flap. Bone removal done around the tooth using a round bur under copious 0.9% normal saline irrigation. The tooth sectioned at cemento-enamel junction whenever required and a Coupland elevator is used to elevate tooth or fragmented tooth out of socket. The socket examined for any debris and sharp bony margins smoothened. The empty socket was irrigated copiously and flap was sutured using three simple interrupted 3-0 black braided silk suture.
Study NCT02837614 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Third molar surgery
Description: Surgical access was gained through standard Terrence Ward's incision to raise a full thickness mucoperiosteal flap. Bone removal done around the tooth using a round bur under copious 0.9% normal saline irrigation. The tooth sectioned at cemento-enamel junction whenever required and a Coupland elevator is used to elevate tooth or fragmented tooth out of socket. The socket examined for any debris and sharp bony margins smoothened. The empty socket was irrigated copiously and flap was sutured using three simple interrupted 3-0 black braided silk suture.
Study NCT02837614 — intervention group
Intervention type: PROCEDURE
Group type: PLACEBO_COMPARATOR
Intervention: Third molar surgery
Description: Surgical access was gained through standard Terrence Ward's incision to raise a full thickness mucoperiosteal flap. Bone removal done around the tooth using a round bur under copious 0.9% normal saline irrigation. The tooth sectioned at cemento-enamel junction whenever required and a Coupland elevator is used to elevate tooth or fragmented tooth out of socket. The socket examined for any debris and sharp bony margins smoothened. The empty socket was irrigated copiously and flap was sutured using three simple interrupted 3-0 black braided silk suture.
Study NCT02837614 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Amoxicillin and paracetamol
Description: Amoxicillin 500 milligram every 8 hours orally for 5 days, and 500 milligram of paracetamol postoperatively (every 6 hours 1 tablet for 2 days).
Study NCT02837614 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Amoxicillin and paracetamol
Description: Amoxicillin 500 milligram every 8 hours orally for 5 days, and 500 milligram of paracetamol postoperatively (every 6 hours 1 tablet for 2 days).
Study NCT02144402 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: infant formula with DHASCO-B
Study NCT00331994 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bacillus clausii
Description: 3 bacillus clausii vials/day for one month
Study NCT00331994 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Metronidazole
Description: 3 Metronidazole tablets/day for one week
Study NCT02318238 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: 6 minutes walking test
Study NCT02318238 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: 6 minutes step test